Brightstar Therapeutics
PrivateLast Round
Series A
Apr 18, 2023
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Brightstar Therapeutics is a biotechnology company that provides innovative treatment options for people living with corneal and ocular surface diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brightstar Therapeutics Comparables
Compare Brightstar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CorneaGen | 87% | |
| BioTissue | 84% | |
| Skye Biologics Holdings | 83% | |
Brightstar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 18, 2023 |
Key People
Founding team and executive leadership
Brightstar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Discovery Capital Funding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 131% MoM, reaching 2.9K.
- Jul 23, 2026
Grew 38% QoQ, from 8 to 11 employees.
Brightstar Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brightstar Therapeutics's valuation, stock price, and market status.